Glycated albumin, a precursor of advanced glycation end‐products, up‐regulates NADPH oxidase and enhances oxidative stress in human endothelial cells: molecular correlate of diabetic vasculopathy
- 6 September 2010
- journal article
- research article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 26 (7) , 550-558
Abstract
Background: Hyperglycaemia induces non‐enzymatic glycation reactions in proteins which generate Amadori products and advanced glycation end‐products; the latter are thought to participate in the vascular complications of diabetic patients. However, the exact mechanisms concerning the effects of glycated proteins on vascular tissue remain to be determined. Therefore, the effects of glycated human serum albumin on human umbilical vein endothelial cells were studied.Methods: Reactive oxygen species production was measured by the cytochrome C reduction method and by 5(6)‐carboxy‐2′,7′‐dichlorofluorescein diacetate (c‐DCF‐DA) fluorescence after treating human umbilical vein endothelial cells with glycated human serum albumin (6–200 µg/mL). The expression of Nox4 and p22phox mRNAs were analysed by reverse transcription‐quantitative polymerase chain reactions and the levels of their proteins were measured by immunofluorescence.Results: Low concentrations of glycated human serum albumin enhanced reactive oxygen species production in human umbilical vein endothelial cells after 4 h of treatment at both extracellular and intracellular sites. This enhanced production was sustained, although to a lesser extent, after 6 and 12 h of treatment. The gene expression study revealed that Nox4 and p22phox mRNA levels were elevated after 4 h of treatment with glycated human serum albumin. This mRNA elevation and enhanced reactive oxygen species production correlated with an increased expression of the Nox4 protein.Conclusions: The results revealed that a circulating and abundant modified glycated human serum albumin protein in diabetic patients induced a sustained reactive oxygen species production in human endothelial cells. This effect may have been due to an up‐regulation of Nox4, the main subunit of NADPH oxidase in the endothelium. Copyright © 2010 John Wiley & Sons, Ltd.Keywords
This publication has 34 references indexed in Scilit:
- Increased glycated albumin and decreased esRAGE levels are related to angiographic severity and extent of coronary artery disease in patients with type 2 diabetesAtherosclerosis, 2009
- Effect of aerobic exercise training on oxidative stress in patients with type 2 diabetes mellitusMetabolism, 2008
- Glycated Albumin Induces Activation of Activator Protein-1 in Retinal Glial CellsJapanese Journal of Ophthalmology, 2007
- Amadori‐glycated albumin‐induced vascular smooth muscle cell proliferation and expression of inhibitor of apoptosis protein‐1 and nerve growth factor‐γBioFactors, 2007
- Amadori-modified glycated albumin predominantly induces E-selectin expression on human umbilical vein endothelial cells through NADPH oxidase activationClinica Chimica Acta, 2006
- Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes: Pathogenic and therapeutic implicationsJournal of Laboratory and Clinical Medicine, 2006
- The Effect of Antioxidants on Glycated Albumin-Induced Cytotoxicity in Bovine Retinal PericytesBiochemical and Biophysical Research Communications, 2002
- Glycated Serum Albumin-Induced Nitric Oxide Production in Vascular Smooth Muscle Cells by Nuclear Factor κB-Dependent Transcriptional Activation of Inducible Nitric Oxide SynthaseBiochemical and Biophysical Research Communications, 1999
- Differential expression of fructosyllysine-specific receptors on monocytes and macrophages and possible pathophysiological significanceDiabetologia, 1996
- Expression of fructosyllysine receptors on human monocytes and monocyte-like cell linesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1995